David B. Bharucha
Chief Medical OfficerDr. David B. Bharucha, M.D, Ph.D., FACC, is Chief Medical Officer of Milestone Pharmaceuticals Inc. from February 15, 2022. Dr. Bharucha is a cardiac electrophysiologist who has global drug development and clinical experience across a range of therapeutic areas, with a focus on cardiovascular medicine. He served as Vice President, Research and Development, Clinical Development at Allergan, a division of AbbVie. Prior to that, Dr. Bharucha held positions of increasing responsibility in Research and Development at Allergan, Actavis, PLC, and Forest Laboratories, where he led multiple U.S. and global programs, including in therapeutic areas of cardiovascular, internal medicine, anti-infectives, women's health and urology, encompassing both new drug application (NDA) and label-expansion approvals. He has served on faculty at Mt. Sinai School of Medicine (NY) and Jefferson Medical University (Philadelphia). Dr. Bharucha's training included fellowships in cardiology and electrophysiology at the Massachusetts General Hospital, Harvard Medical School. Dr. Bharucha received his M.D. (Honors) and Ph.D. (Biochemistry and Molecular Biology) from The University of Chicago, and his B.A. in Biology from Haverford College.
Positions
- Company NameMilestone Pharmaceuticals Inc.Stock CodeMISTPositionChief Medical OfficerColleagues
- JGJoseph G. OlivetoCEO, President & Executive Director
- RJRobert James WillsIndependent Chairman of the Board
- AHAmit HasijaCFO & Executive VP of Corporate Development
- PDPhilippe DouvilleFounder, Strategic Advisor & Member of Scientific Advisory Board
- JNJeffrey NelsonChief Operating Officer
- PTPhilip T. SagerChief Medical Advisor & Member of the Scientific Advisory Board
- MJMichael John TomsicekIndependent Non-Executive Director
